1, 3-β-D-glucan, Candidemia, Intensive Care Unit
Showing 1 - 25 of >10,000
Dosage of Plasma 1, 3-ß-D-glucan for Diagnosis of Candidemia.
Recruiting
- Infection, Fungal
- BDG analysis
-
Bobigny, France
- +1 more
Jan 24, 2021
Invasive Fungal Infections Trial (procalcitonin ,CRP and 1, 3- ß -D- glucan in early diagnosis of invasive infections)
Not yet recruiting
- Invasive Fungal Infections
- procalcitonin ,CRP and 1, 3- β -D- glucan in early diagnosis of invasive infections
- (no location specified)
Feb 10, 2023
Cardiometabolic Syndrome Trial in Malang (ß-1,3/1,6-D-Glucan From Mycelia Extract of Indonesia's Ganoderma Lucidum Group,
Enrolling by invitation
- Cardiometabolic Syndrome
- β-1,3/1,6-D-Glucan From Mycelia Extract of Indonesia's Ganoderma Lucidum Group
- Placebo Group
-
Malang, East Java, IndonesiaGeneral Hospital of Brawijaya University (Rumah Sakit Universita
Oct 3, 2021
Type 1 Diabetes Trial in Shanghai (Cholecalciferol (Vit D3) 400Unit Cap)
Not yet recruiting
- Type 1 Diabetes
- Cholecalciferol (Vit D3) 400Unit Cap
-
Shanghai, ChinaDepartment of Pediatrics, Ruijin Hospital, Shanghai Jiao Tong Un
May 20, 2022
Tracheostomy Weaning Trial in Sherbrooke (Suctioning based protocol, Usual Care)
Not yet recruiting
- Tracheostomy Weaning
- Suctioning based protocol
- Usual Care
-
Sherbrooke, Quebec, CanadaUniversité de Sherbrooke
Mar 9, 2023
Children After Hospitalization in Intensive Care Unit
Not yet recruiting
- Renal Disease
- +7 more
- neurocognitive tests
-
Calgary, Alberta, Canada
- +7 more
Nov 3, 2023
Intensive Care Unit Management After Cardiac ARrest in Russia
Recruiting
- Post Cardiac Arrest Syndrome
-
Irkutsk, Russian Federation
- +10 more
Oct 24, 2022
Sedation Trial in Nashville (Isoflurane, Propofol)
Recruiting
- Sedation
-
Nashville, TennesseeVanderbilt University Medical Center
May 2, 2022
Dietary Supplements, Intensive Care Unit, Vitamin D Deficiency Trial (Vitamin D supplementation)
Completed
- Dietary Supplements
- +3 more
- Vitamin D supplementation
- (no location specified)
Jun 14, 2021
Uveitis Trial in Jakarta Pusat (Beta-1,3/1,6-D-Glucan Ganoderma lucidum, Placebos)
Recruiting
- Uveitis
- Beta-1,3/1,6-D-Glucan Ganoderma lucidum
- Placebos
-
Jakarta Pusat, DKI Jakarta, IndonesiaRSCM Kirana
Feb 1, 2021
Sepsis Trial in Worldwide (Anakinra or rhIFN?, Placebo)
Recruiting
- Sepsis
- Anakinra or rhIFNγ
- Placebo
-
Jena, Germany
- +25 more
Jul 13, 2022
Pain, Acute, Distress, Emotional, Critical Illness Trial in Montréal (Patient-Oriented Music Intervention (POMI))
Recruiting
- Pain, Acute
- +2 more
- Patient-Oriented Music Intervention (POMI)
-
Montréal, Quebec, CanadaJewish General Hospital
Apr 1, 2022
Invasive Candidiasis Trial in Italy (1,3-ß-D-glucan quantification, Micafungin)
Terminated
- Invasive Candidiasis
- 1,3-β-D-glucan quantification
- Micafungin
-
Acquaviva Delle Fonti, Italy
- +19 more
Apr 8, 2021
Delirium, Intensive Care Unit Delirium, Post Intensive Care Unit Syndrome Trial in Calgary (Delirium Education, Prevention, and
Recruiting
- Delirium
- +3 more
- Delirium Education, Prevention, and Management
- Standard Care
-
Calgary, Alberta, Canada
- +3 more
Oct 7, 2021
Premature Infant, Respiratory Distress Syndrome in Premature Infant, Neurodevelopmental Outcome Trial in Calgary, Edmonton,
Recruiting
- Premature Infant
- +2 more
- 30% oxygen group
- 60% oxygen group
-
Calgary, Alberta, Canada
- +5 more
Oct 4, 2022
Osteopenia of Prematurity Trial in Alexandria (Low Dose Vitamin D, High Dose Vitamin D)
Completed
- Osteopenia of Prematurity
- Low Dose Vitamin D
- High Dose Vitamin D
-
Alexandria, EgyptNeonatal Intensive Care Unit (NICU) of Alexandria University Mat
Sep 11, 2021
Dyssomnias Trial in Santiago de Chile (behavioral, other, device)
Recruiting
- Dyssomnias
- Sueña component 1: Sleep Hygiene Promotion
- +5 more
-
Santiago de Chile, Región Metropolitana, ChileClínica San Carlos de Apoquindo UC
Sep 15, 2021
Squamous Cell Cancer of Head and Neck (SCCHN), NSCLC (NSCLC), Colorectal Cancer Trial in Australia (MVC-101 (TAK-186))
Recruiting
- Squamous Cell Cancer of Head and Neck (SCCHN)
- +2 more
- MVC-101 (TAK-186)
-
Randwick, New South Wales, Australia
- +3 more
Sep 14, 2022
Intensive Care Unit, Mechanical Ventilation, Anesthesia Trial in Nanjing (Remimazolam 0.1mg/kg/h, Remimazolam 0.3mg/kg/h,
Active, not recruiting
- Intensive Care Unit
- +4 more
- Remimazolam 0.1mg/kg/h
- +2 more
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital with Nanjing Medical University
Jul 27, 2022
Acute Respiratory Distress Syndrome, Hypoxemic Respiratory Failure, ARDS, Human Trial in Canada (TheraPPP)
Recruiting
- Acute Respiratory Distress Syndrome
- +2 more
- TheraPPP
-
Calgary, Alberta, Canada
- +16 more
Jul 21, 2022
Patient Safety, Well-being, Education Trial in Toronto (16h overnight duty, 24h overnight duty, Handover training)
Recruiting
- Patient Safety
- +2 more
- 16h overnight duty
- +2 more
-
Toronto, Ontario, Canada
- +3 more
Feb 18, 2021
Cognitive Disorders Trial in Russian Federation (MMH-MAP, Placebo)
Active, not recruiting
- Cognitive Disorders
- MMH-MAP
- Placebo
-
Arkhangelsk, Russian Federation
- +21 more
Jan 20, 2023
Covid19, SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere Trial in France (Patch, Nicotine, Patch, Placebo)
Completed
- Covid19
- SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere
- Patch, Nicotine
- Patch, Placebo
-
Argenteuil, France
- +17 more
Jun 21, 2021
Non-Alcoholic Steatohepatitis Trial in Worldwide (Yaq-001, Placebo)
Withdrawn
- Non-Alcoholic Steatohepatitis
- Yaq-001
- Placebo
-
Clichy, France
- +8 more
Feb 14, 2022
Candidemia, Mycoses, Fungal Infection Trial in Worldwide (Rezafungin for Injection, Caspofungin, Fluconazole)
Completed
- Candidemia
- +3 more
- Rezafungin for Injection
- +4 more
-
Birmingham, Alabama
- +131 more
Dec 13, 2022